The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE
暂无分享,去创建一个
A. Lincoff | S. Nissen | E. McErlean | S. Nicholls | L. Cho | K. Wolski | J. Riesmeyer | G. Weerakkody | G. Ruotolo | Nishant P. Shah | V. Menon | Qiuqing Wang